235 related articles for article (PubMed ID: 31799190)
1. Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
Mattheolabakis G; Mikelis CM
Front Oncol; 2019; 9():1227. PubMed ID: 31799190
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
3. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
Shen Y; Li S; Wang X; Wang M; Tian Q; Yang J; Wang J; Wang B; Liu P; Yang J
J Exp Clin Cancer Res; 2019 Oct; 38(1):427. PubMed ID: 31656203
[TBL] [Abstract][Full Text] [Related]
4. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
5. Vascular permeability and drug delivery in cancers.
Azzi S; Hebda JK; Gavard J
Front Oncol; 2013; 3():211. PubMed ID: 23967403
[TBL] [Abstract][Full Text] [Related]
6. Smart Nanotherapeutic Targeting of Tumor Vasculature.
Li Z; Di C; Li S; Yang X; Nie G
Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
[TBL] [Abstract][Full Text] [Related]
7. "Targeted plus controlled" - Composite nano delivery system opens the tumor vascular and microenvironment normalization window for anti-tumor therapy.
Shen R; Jiang Q; Li P; Wang D; Yu C; Meng T; Hu F; Yuan H
Int J Pharm; 2023 Nov; 647():123512. PubMed ID: 37839496
[TBL] [Abstract][Full Text] [Related]
8. Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect.
Huang D; Sun L; Huang L; Chen Y
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672813
[TBL] [Abstract][Full Text] [Related]
9. Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
Kim SJ; Jung KH; Son MK; Park JH; Yan HH; Fang Z; Kang YW; Han B; Lim JH; Hong SS
Cancer Lett; 2017 Sep; 403():339-353. PubMed ID: 28688971
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
Majidpoor J; Mortezaee K
Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition.
Taleb M; Atabakhshi-Kashi M; Wang Y; Rezvani Alanagh H; Farhadi Sabet Z; Li F; Cheng K; Li C; Qi Y; Nie G; Ying Z
Adv Healthc Mater; 2021 Jun; 10(12):e2100051. PubMed ID: 34021735
[TBL] [Abstract][Full Text] [Related]
12. Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation.
Liang Q; Zhou L; Li Y; Liu J; Liu Y
J Drug Target; 2022 Feb; 30(2):119-130. PubMed ID: 33960252
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?
Augustin HG; Koh GY
Cancer Res; 2022 Jan; 82(1):15-17. PubMed ID: 34983784
[TBL] [Abstract][Full Text] [Related]
14. Dopamine Delivery via pH-Sensitive Nanoparticles for Tumor Blood Vessel Normalization and an Improved Effect of Cancer Chemotherapeutic Drugs.
Taleb M; Ding Y; Wang B; Yang N; Han X; Du C; Qi Y; Zhang Y; Sabet ZF; Alanagh HR; Mujeeb A; Khajeh K; Nie G
Adv Healthc Mater; 2019 Sep; 8(18):e1900283. PubMed ID: 31379139
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
Maione F; Giraudo E
Methods Mol Biol; 2015; 1267():349-65. PubMed ID: 25636478
[TBL] [Abstract][Full Text] [Related]
16. Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound.
Ho YJ; Chu SW; Liao EC; Fan CH; Chan HL; Wei KC; Yeh CK
Theranostics; 2019; 9(24):7370-7383. PubMed ID: 31695774
[TBL] [Abstract][Full Text] [Related]
17. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?
Denekamp J; Daşu A; Waites A
Adv Enzyme Regul; 1998; 38():281-99. PubMed ID: 9762359
[TBL] [Abstract][Full Text] [Related]
18. Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: A hypothesis.
Swamy K
Med Hypotheses; 2021 Jul; 152():110618. PubMed ID: 34102599
[TBL] [Abstract][Full Text] [Related]
19. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy.
Wu JB; Tang YL; Liang XH
Onco Targets Ther; 2018; 11():6901-6909. PubMed ID: 30410348
[TBL] [Abstract][Full Text] [Related]
20. Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.
Theek B; Baues M; Gremse F; Pola R; Pechar M; Negwer I; Koynov K; Weber B; Barz M; Jahnen-Dechent W; Storm G; Kiessling F; Lammers T
J Control Release; 2018 Jul; 282():25-34. PubMed ID: 29730154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
